Vaughan-Shaw, Peter G.
Buijs, Louis F.
Blackmur, James P.
Theodoratou, Evi
Zgaga, Lina
Din, Farhat V. N.
Farrington, Susan M.
Dunlop, Malcolm G.
Funding for this research was provided by:
Cancer Research UK (C157/A23218)
ECAT-linked CRUK ECRC Clinical training award
Article History
Received: 13 May 2020
Revised: 21 August 2020
Accepted: 26 August 2020
First Online: 15 September 2020
Ethics approval and consent to participate
: Not required; data were collected for previously published studies.
: Available at reasonable requests from pvaughan@ed.ac.uk.
: The authors declare no competing interests
: This work was supported by funding for the infrastructure and staffing of the Edinburgh CRUK Cancer Research Centre; CRUK programme grant C348/A18927 (M.G.D.). P.G.V.-S. was supported by a NES SCREDS clinical lectureship. J.P.B. is supported by an ECAT-linked CRUK ECRC Clinical training award (C157/A23218). E.T. is supported by a CRUK Career Development Fellowship (C31250/A22804). F.V.N.D. is supported by a CSO Senior Clinical Fellowship. This work was also funded by a grant to M.G.D. as Project Leader with the MRC Human Genetics Unit Centre Grant (U127527202 and U127527198 from 1/4/18).